coronavirida
repres
import
famili
anim
human
virus
perman
circul
four
common
human
coronavirus
caus
respiratori
infect
worldwid
present
contin
tabl
mortal
poorli
assess
clear
chronic
carrier
well
asymptomat
carrier
studi
shown
mani
asymptomat
carrier
symptomat
patient
three
epidem
episod
emerg
coronavirus
report
first
sever
acut
respiratori
syndrom
sar
coronaviru
littl
impact
global
morbid
mortal
recogn
case
death
second
middl
east
respiratori
syndrom
mer
coronaviru
remain
local
saudi
arabia
small
epidem
mainli
nosocomi
infect
south
korea
merscoronaviru
like
sarscoronaviru
highlight
major
danger
nosocomi
transmiss
healthcar
personnel
health
essenti
epidem
final
novel
coronaviru
appear
decemb
expand
affect
peopl
worldwid
time
write
signific
number
case
occur
far
east
incontest
contagi
quasiexperiment
studi
diamond
princess
cruis
ship
show
confin
infect
patient
uninfect
patient
result
rapid
infect
uninfect
patient
lead
addit
case
board
howev
coronavirus
common
circul
remain
predomin
global
distribut
nonneglig
mortal
aim
studi
share
experi
refer
laboratori
repres
approxim
seriou
diagnos
respiratori
infect
particularli
season
franc
allow
evalu
rel
mortal
differ
human
coronavirus
present
hospit
marseil
compar
assist
de
marseil
aphm
cover
public
hospit
marseil
includ
four
univers
hospit
la
timon
hospit
concept
hospit
north
hospit
south
hospit
correspond
bed
admiss
year
ihu
infect
diagnost
laboratori
test
sampl
aphm
respiratori
virus
suspect
molecular
biolog
use
diagnosi
result
monitor
weekli
autom
surveil
system
diagnost
laboratori
coupl
laboratori
informa
guangzou
china
zeng
guangzou
china
killerbi
usa
kiyuka
kenya
owusu
ghana
case
dube
south
africa
control
tuberculosi
sipulwa
kenya
subramoney
south
africa
nune
south
africa
leviet
vietnam
tion
system
nexlab
epidemiolog
data
obtain
onlin
platform
gather
data
public
agenc
statist
analys
perform
use
biostatgv
softwar
death
franc
death
occur
care
establish
year
aphm
report
death
estim
approxim
death
care
establish
franc
occur
aphm
hospit
estim
provid
approxim
number
peopl
affect
pathogen
franc
accord
number
peopl
die
year
aphm
hospit
januari
decemb
sampl
test
ihu
infect
diagnost
laboratori
among
sampl
posit
coronaviru
eight
death
mortal
rate
among
identifi
coronavirus
identifi
one
death
mortal
rate
identifi
two
death
mortal
rate
identifi
one
death
mortal
rate
identifi
four
death
mortal
rate
three
hundr
eightyon
coronavirus
diagnos
assign
four
strain
tabl
systemat
test
molecular
biolog
perform
januari
march
total
sampl
patient
present
infecti
symptom
test
ihu
infect
diagnost
laboratori
among
sampl
posit
coronavirus
two
death
mortal
rate
sampl
sampl
sampl
sampl
case
identifi
among
sam
ple
two
death
one
patient
mortal
rate
one
patient
mortal
rate
death
period
period
ihu
infect
region
centr
detect
novel
coronaviru
time
write
analys
perform
suspect
case
sinc
emerg
novel
pathogen
four
case
identifi
addit
french
nation
return
hubei
provinc
test
twice
neg
march
total
patient
test
posit
worldwid
death
mortal
rate
among
organis
econom
cooper
develop
oecd
countri
patient
test
posit
death
mortal
rate
tabl
franc
peopl
test
posit
three
death
mortal
rate
studi
compar
mortal
rate
oecd
countri
mortal
rate
common
coronavirus
identifi
aphm
patient
januari
march
chisquar
test
perform
p
valu
signific
studi
found
mortal
rate
common
coronaviru
infect
franc
comparison
mortal
rate
european
american
develop
countri
compar
econom
level
tabl
extrapol
death
aphm
hospit
correct
metropolitan
franc
would
repres
case
patient
hospit
respiratori
infect
common
coronavirus
month
almost
mani
case
worldwid
fact
mortal
respiratori
infect
extrem
depend
qualiti
care
access
care
littl
chanc
emerg
could
chang
statist
significantli
fear
could
larger
impact
viru
case
suicid
motiv
fear
report
india
addit
coronavirus
rare
test
systemat
around
world
may
persist
pharynx
asymptomat
peopl
repres
potenti
sourc
popul
immun
furthermor
note
systemat
studi
coronavirus
yet
found
percentag
asymptomat
carrier
equal
even
higher
percentag
symptomat
patient
data
may
soon
avail
reduc
rel
risk
associ
specif
patholog
fund
work
support
french
govern
invest
futur
programm
manag
nation
agenc
research
ethic
approv
applic
test
repatri
approv
ethic
board
committe
protect
person
cpp
ile
de
franc
vi
februari
